Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440866 | PMC |
| http://dx.doi.org/10.1016/S2352-4642(20)30257-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Scleroderma renal crisis with overlap to dermatomyositis triggered by COVID-19 infection: a case report.
Mod Rheumatol Case Rep
July 2025
Department of Rheumatology, Shonan Kamakura General Hospital, Kamakura-shi, Kanagawa 247-8533, Japan.
A 46-year-old man was diagnosed with anti jo-1 antibody-positive dermatomyositis 11 years ago and had been treated with prednisolone and tacrolimus. In the present case, after contracting SARS-CoV-2 virus infection, his dyspnoea rapidly worsened, and he presented with renal and cardiac failure. Based on the biopsy results of the same area and anti-U1-RNP antibody positivity, he was diagnosed with systemic sclerosis and scleroderma renal crisis and required haemodialysis.
View Article and Find Full Text PDFSafety and 1-Year Outcomes After Transplanting Hearts From SARS-CoV-2 Positive Donors: Insights From an International Analysis.
Immun Inflamm Dis
September 2025
Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA.
Background: Uncertainties persist regarding the utilization of hearts from SARS-CoV-2-positive donors for heart transplant (HT). This international study analyzed such HTs within the United States (US) and Germany, focusing on 1-year outcomes and granular safety data.
Methods: Data was obtained from the United Network for Organ Sharing (UNOS) registry (03/2021-08/2022) and collaborating with the German Organ Procurement Organisation (DSO; 03/2022-02/2023).
Health risk assessment for severe COVID-19 in Taiwan: a multi-centre electronic health record study.
J Glob Health
September 2025
International Ph.D. Program in Biotech and Healthcare Management, College of Management, Taipei Medical University, Taipei, Taiwan.
Background: As the global battle against COVID-19 continues, understanding the factors contributing to severe outcomes remains critical for public health strategies. We aim to identify the determinants significantly influencing severe COVID-19 infection and mortality among the general population in Taiwan.
Methods: We conducted a retrospective cohort study using data extracted from the Taipei Medical University Clinical Research Database from 1 January 2022 to 31 December 2022.
Strategies for population-level identification of post-acute sequelae of COVID-19 through health administrative data.
Front Public Health
September 2025
Epidemiology Unit, Agency for Health Protection Milan, Milan, Italy.
Introduction: Post-acute sequelae of COVID-19 (PASC) encompass several clinical outcomes, from new-onset symptoms to both acute and chronic diagnoses, including pulmonary and extrapulmonary manifestations. Health administrative data (HAD) from health information systems allow population-level analyses of such outcomes. Our primary aim was to identify clinical conditions potentially attributable to SARS-CoV-2 infection, and the types of HAD and "diagnostic criteria" used for their detection.
View Article and Find Full Text PDFTens of thousands of severe COVID-19 cases are hospitalized weekly in the U.S., often driven by an imbalance between antiviral responses and inflammatory signaling, leading to uncontrolled cytokine secretion.
View Article and Find Full Text PDF